Delivery Order SPE2DB22D1106-SPE2DB25FFHT7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,144.26 firm-fixed-price contract is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various government agencies, including the DLA and the Department of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,348.46 contract is for the supply of 20,000 units of the medication PROCRIT (2 mL vials) with a completion date of May 19, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,666.43 contract is for the delivery of 40,000 units/mL vials of the pharmaceutical product PROCRIT. The delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division,...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.50 to AmerisourceBergen Drug Corp for Prostin VR Pedi 500 mcg/mL, a pharmaceutical product used in pediatric healthcare applications. The contract, which is classified as a firm fixed price delivery order with no set-aside designation, was awarded on August 15, 2025, and is scheduled for completion by August 18, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 29, 2025, valued at $2,451.24 for the supply of Protamine 50 mg/5 mL vials. This competitively awarded, firm fixed-price contract is funded by the Medical Supply Chain, a defense agency component, with a completion date of July 30, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a $7,117.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of September 11, 2025. This competitively awarded delivery order, issued without set-aside designation, represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,714.50 to AmerisourceBergen Drug Corp for PROLIA 60 mg/ml syringes, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA Troop Support. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a $12,726.40 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of July 28, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHT7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,671.66 to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit, a pharmaceutical product used to treat anemia. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX indefinite delivery vehicle serves as a comprehensive pharmaceutical support contract enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. Through this prime vendor arrangement, the company supplies critical pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Troop Support is planning to establish subsequent generation contracts under its Pharmaceutical Prime Vendor Global Program, potentially awarding separate regional contracts to multiple vendors, demonstrating the agency's strategy to maintain flexible and comprehensive pharmaceutical supply capabilities across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 9/9/25 |